Cherubisam
cherubism clinical features pathology treatment 2024
| Feature | Details |
|---|---|
| Facial appearance | Bilateral, symmetric fullness/swelling of the lower face (jaw) - "chubby cheeks" resembling cherubs in Renaissance paintings |
| Mandible | Most prominently affected - posterior rami/angles |
| Maxilla | Also affected in more severe cases |
| Eyes | Upward deviation of the eyes (exposure of inferior sclera) due to floor of orbit involvement; can cause visual problems in severe disease |
| Teeth | Delayed eruption, displacement, mobility, root resorption, failure of permanent teeth to develop |
| Lymph nodes | Submandibular and cervical lymphadenopathy |
| Speech/Swallowing | Impaired in severe cases |
| Respiratory | Can cause airway compromise in aggressive disease |
| Approach | Details |
|---|---|
| Watchful waiting | First-line for most; majority regress spontaneously after puberty (increased sex steroids normalize osteoclast activity) |
| Surgery | Reserved for significant cosmetic deformity, functional compromise (airway, vision, swallowing), or aggressive lesions. Includes curettage, osteoplasty, bone recontouring |
| Curettage | Associated with ~15% recurrence; excision preferred where possible |
| Dental management | Extraction of teeth from areas of fibrous change |
| Denosumab | Emerging therapy - a 2024 report documented successful treatment with denosumab 60 mg every 6 months in adult cherubism, targeting osteoclast activity via RANKL inhibition |
| Timing | Early surgical intervention before puberty may be needed in severe cases; conservative post-pubertal recontouring is preferred if possible |